Evidence map›Paper›PMID 30968409›Full record

ReviewClinical and experimental immunology2019

HLA-E: exploiting pathogen-host interactions for vaccine development.

H R Sharpe, G Bowyer, S Brackenridge, T Lambe

Open access · hybridAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. A cytoplasmic motif in HLA-E that drives clathrin-mediated endocytosis and VCP-associated postendocytic trafficking.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Intracellular trafficking of HLA-E and its regulation.The Journal of experimental medicine · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

H R SharpeNuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK.ORCID 0000-0002-1194-2429
G BowyerNuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK.ORCID 0000-0002-2058-4045
S BrackenridgeNuffield Department of Medicine, NDM Research Building, University of Oxford, Oxford, UK.ORCID 0000-0002-0587-7560
T LambeNuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK.ORCID 0000-0001-7711-897X
Jenner Institute · GBUniversity of Oxford · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Viruses, when used as vectors for vaccine antigen delivery, can induce strong cellular and humoral responses against target epitopes. Recent work by Hansen et al. describes the use of a cytomegalovirus-vectored vaccine, which is able to generate a stable effector-memory T cell population at the sites of vaccination in rhesus macaques. This vaccine, targeted towards multiple epitopes in simian immunodeficiency virus (SIV), did not induce classical CD8

Indexed as

AnimalsHLA AntigensHost-Pathogen InteractionsHumansVaccinesHLA AntigensVaccinescytomegalovirusHLA-Etrained immunityvaccines

Identifiers

PMID30968409
PMCPMC6468186
OpenAlexW2937561625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.